We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Align Technology at 52-Week High: What's Driving the Stock?
Read MoreHide Full Article
Share price of Align Technology, Inc. (ALGN - Free Report) scaled a new 52-week high of $246.84 on Nov 7, closing nominally lower at $246.46. The company has gained 78.4% over the last six months, much higher than the S&P 500’s gain of 8.2%. Align Technology has also beat the broader industry’s gain of 5.3% with respect to share price over the last six months. The stock has a market cap of $19.76 billion.
Further, Align Technology’s estimate revision trend for the current year is favorable. In the past 60 days, nine estimates moved up while one shifted down. Consequently, estimates were up from $3.40 per share to $3.56.
The company also has a trailing four-quarter average positive earnings surprise of 16.6%. Its positive long-term growth of 28.9% holds promise as well.
The company’s five-year historical growth rate is also favorable at 19.5% as compared with the broader industry’s 8.4% and the S&P 500’s 2.8%.
Align Technology sports a Zacks Rank #1 (Strong Buy). The company has an impressive Growth Style Score of B. Our Growth Style Score highlights all the vital metrics of a company’s financials to obtain a clearer picture of the quality and sustainability of its growth. Our research shows that stocks with Style Scores of A or B when combined with a Zacks Rank #1, 2 (Buy) or 3 (Hold) offer the best investment opportunities.
The market is upbeat about Align Technology’s recently reported impressive third-quarter performance. The year-over-year growth in earnings and revenues is encouraging. Additionally, the company has a strong cash balance that enables it to carry out share repurchases and in turn provide solid returns to investors. The expansion in gross and operating margin also buoys optimism. The company is also constantly investing in R&D for product innovation.
Recently, the company opened its first office in Canada to support growth in the region. According to the company, Canada is its second-largest market based on Invisalign case volumes.
Align Technology has also become part of the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index recently.
All these factors are expected to boost the company’s share price.
Other Key Picks
Other top-ranked stocks in the broader medical sector are PetMed Express, Inc. (PETS - Free Report) , Luminex Corporation and Intuitive Surgical, Inc. (ISRG - Free Report) . Notably, PetMed and Luminex sport a Zacks Rank #1, while Intuitive Surgical carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
PetMed has a long-term expected earnings growth rate of 10%. The stock has rallied roughly 91.7% over the last year.
Luminexhas a long-term expected earnings growth rate of 16.3%. The stock has gained 8.6% in the last year.
Intuitive Surgical has a long-term expected earnings growth rate of 9.1%. The stock has gained 71.2% in the last year.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Align Technology at 52-Week High: What's Driving the Stock?
Share price of Align Technology, Inc. (ALGN - Free Report) scaled a new 52-week high of $246.84 on Nov 7, closing nominally lower at $246.46. The company has gained 78.4% over the last six months, much higher than the S&P 500’s gain of 8.2%. Align Technology has also beat the broader industry’s gain of 5.3% with respect to share price over the last six months. The stock has a market cap of $19.76 billion.
Further, Align Technology’s estimate revision trend for the current year is favorable. In the past 60 days, nine estimates moved up while one shifted down. Consequently, estimates were up from $3.40 per share to $3.56.
The company also has a trailing four-quarter average positive earnings surprise of 16.6%. Its positive long-term growth of 28.9% holds promise as well.
The company’s five-year historical growth rate is also favorable at 19.5% as compared with the broader industry’s 8.4% and the S&P 500’s 2.8%.
Align Technology sports a Zacks Rank #1 (Strong Buy). The company has an impressive Growth Style Score of B. Our Growth Style Score highlights all the vital metrics of a company’s financials to obtain a clearer picture of the quality and sustainability of its growth. Our research shows that stocks with Style Scores of A or B when combined with a Zacks Rank #1, 2 (Buy) or 3 (Hold) offer the best investment opportunities.
Align Technology, Inc. Price and Consensus
Align Technology, Inc. Price and Consensus | Align Technology, Inc. Quote
Growth Drivers
The market is upbeat about Align Technology’s recently reported impressive third-quarter performance. The year-over-year growth in earnings and revenues is encouraging. Additionally, the company has a strong cash balance that enables it to carry out share repurchases and in turn provide solid returns to investors. The expansion in gross and operating margin also buoys optimism. The company is also constantly investing in R&D for product innovation.
Recently, the company opened its first office in Canada to support growth in the region. According to the company, Canada is its second-largest market based on Invisalign case volumes.
Align Technology has also become part of the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index recently.
All these factors are expected to boost the company’s share price.
Other Key Picks
Other top-ranked stocks in the broader medical sector are PetMed Express, Inc. (PETS - Free Report) , Luminex Corporation and Intuitive Surgical, Inc. (ISRG - Free Report) . Notably, PetMed and Luminex sport a Zacks Rank #1, while Intuitive Surgical carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
PetMed has a long-term expected earnings growth rate of 10%. The stock has rallied roughly 91.7% over the last year.
Luminexhas a long-term expected earnings growth rate of 16.3%. The stock has gained 8.6% in the last year.
Intuitive Surgical has a long-term expected earnings growth rate of 9.1%. The stock has gained 71.2% in the last year.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>